The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSIGB.L Regulatory News (SIGB)

  • There is currently no data for SIGB

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Results 8 November 2012 - 31 December 2013

31 Mar 2014 07:00

RNS Number : 5221D
Sherborne Investors (Guernsey)B Ltd
31 March 2014
 



Sherborne Investors (Guernsey) B Limited

31 March 2014

 

SHERBORNE INVESTORS (GUERNSEY) B LIMITED

 

ANNUAL RESULTS FOR THE PERIOD FROM 8 NOVEMBER 2012 TO 31 DECEMBER 2013

 

The Directors of Sherborne Investors (Guernsey) B Limited announce the results for the period from 8 November 2012 to 31 December 2013.

 

COMPANY SUMMARY

 

The Company

The Company is a Guernsey domiciled limited company and its shares are admitted to trading on the London Stock Exchange's Specialist Fund Market ("SFM") market. The Company was incorporated on 08 November 2012. The Company commenced dealings on AIM on 29 November 2012 and moved from AIM market to the SFM on 7 May 2013.

Investment Objective and Policy

The Company's investment objective, through its investment in the Investment Partnership, is to realise capital growth from investment in a target company identified by the Investment Manager with the aim of generating a significant capital return for Shareholders.

 

The Company's investment policy is to invest in a company which is publicly quoted, most likely on a UK stock exchange, which it considers to be undervalued as a result of operational deficiencies and which it believes can be rectified by the Investment Manager's active involvement, thereby increasing the value of the investment. The Company will only invest in one target company at a time.

Investment Manager

The General Partner and the Investment Partnership have appointed Sherborne Investors Management (Guernsey) LLC to provide investment management services to the Investment Partnership.

 

Talmai Morgan, Chairman of the Board, said:

 

Our initial public offering of shares was completed on 29 November 2012, raising gross proceeds of £207.0 million. The net proceeds of the offering were placed in short-term bank deposits pending investment in a limited partnership interest in SIGB, LP. Shortly after the offering, the Board approved a turnaround investment in 3i Group plc ("3i") which was proposed by SIGB, LP's investment manager, Sherborne Investors Management (Guernsey) LLC ("SIMG"). During 2013, SIGB, LP acquired approximately 5% of 3i's outstanding shares.

 

During the period our Chairman, Mr Ian Brindle, retired from the Board of the Company, at which time I became Chairman. During the first half of 2013, Mr Christopher Legge also joined the Board of the Company. I thank Ian for his many contributions culminating with the Company's successful offering. Chris brings additional skills to the Board, and Trevor and I look forward to working closely with him.

 

In November 2013, the Investment Manager informed the Company that 3i would no longer be pursued as a turnaround investment. At that time a portion of the investment was sold and the remaining economic exposure of SIGB, LP to 3i's shares was offset through the use of derivatives, resulting in an economic net neutral position in 3i shares. The Company declared a dividend of 20 pence per share which was approximately equal to the net profit generated by SIGB, LP on its investment in 3i and which was paid to shareholders in December 2013. Total dividends paid in 2013 totalled £44.0 million, or 21.25 pence per share, representing a 21.25 % return on the gross amount raised in our IPO in November

2012.

 

At 31 December 2013, the net asset value attributable to shareholders of the Company was £197.4 million or 95.4 pence per share, net of the total dividends paid of £44.0 million during the year 2013. The net asset value at 31 December 2013 reflects a residual investment in 37,883,701 shares of 3i which together with derivative securities were subsequently sold in January 2014.

 

In December 2013, SIMG proposed an investment by SIGB, LP in a New Selected Target Company. The Board of Directors of the Company approved the proposed New Selected Target Company investment and the price up to which SIMG could purchase shares in it. In January 2014, SIGB, LP began to acquire an economic interest in the New Selected Target Company. On 28 February 2014, Electra Private Equity plc ("Electra") released to the market a TR-1 notification from SIMG which stated that as of 25 February 2014, SIGB, LP beneficially held an economic interest in 3,619,114 ordinary shares, or approximately 10.24% of Electra's outstanding shares, represented by a combination of ordinary shares and total return swaps. SIMG has informed the Company that, as at 21 March 2014 SIGB, LP has an economic interest in 6,653,435 ordinary shares or approximately 18.83% of Electra's outstanding shares. Pursuant to its existing authority, SIMG may sell, short or otherwise dispose of all or a part of such shares held in Electra or purchase additional shares at any time.

 

We are grateful for your continued support and will keep you informed of the status of our investments as they develop.

 

Yours sincerely

 

Talmai Morgan

Chairman

 

Sherborne Investors (Guernsey) B Limited

28 March 2014

 

 

BOARD OF DIRECTORS

 

Talmai Morgan (61) (Chairman)

Appointed to the Board 8 November 2012

Mr. Morgan has been a non-executive director of a number of investment companies since 2005. He is currently chairman of four publicly listed companies and a director of a further five such companies, including Sherborne Investors (Guernsey) A Limited (in members' voluntary liquidation). Previously, from July 2004 to May 2005, he was Chief Executive of Guernsey Finance, which is the official body for the promotion of the Guernsey finance industry. From January 1999 to June 2004, Mr. Morgan was Director of Fiduciary Services and Enforcement at the Guernsey Financial Services Commission where he was responsible for the design and implementation of Guernsey's law relating to the regulation of fiduciaries, administration businesses and company directors. He was also particularly involved in Working Groups of the Financial Action Task Force and the Offshore Group of Banking Supervisors. Prior to 1999, Mr. Morgan held positions at Barings and the Bank of Bermuda. Mr Morgan holds an M.A. in economics and law from the University of Cambridge.

 

Trevor Ash (67) (Audit Committee Chairman for the period)

Appointed to the Board 8 November 2012

Mr. Ash has been a non-executive director of a number of investment entities since 1999, including Sherborne Investors (Guernsey) A Limited (in members' voluntary liquidation) and funds managed by Rothschild, Insight, Cazenove, Merrill Lynch and Thames River Capital. He is currently Chairman of J.P. Morgan Private Equity Limited. Prior to 1999, Mr. Ash spent 27 years with the Rothschild Group in various capacities, most recently as Managing Director of Rothschild Asset Management (CI) Limited and as a non-executive director of Rothschild Asset Management Limited in London.

 

Christopher Legge (58) (Director)

Appointed to the Board 10 May 2013

Mr. Legge is a Chartered Accountant having started his career at Pannell Kerr Forster (PKF), before moving to Ernst & Young in 1983, where he became a partner in 1986 and managing partner Guernsey in 1998. Since leaving Ernst & Young in 2003 he has taken on a number of non-executive directorships. He is currently Senior Independent Director of BH Macro Limited, non-executive director of Third Point Offshore Investors Limited, non-executive director of Ashmore Global Opportunities Limited, non-executive Director of Multi-Manager Investment Programmes PCC Limited, non-executive Director of Baring Vostok Investments PCC Limited and a non-executive Director of TwentyFour Select Monthly Income fund Limited. Mr. Legge is an FCA and holds a BA (Hons) in Economics from the University of Manchester.

 

Ian Brindle (70) (Chairman)

Appointed to the Board 8 November 2012

Retired from the Board on 7 May 2013

On 10 April 2013, the Company announced Mr Brindle's retirement from the Board of the Company upon migration from AIM to the SFM. This took place on 7 May 2013.

 

 

DIRECTORS' REPORT

 

The Directors present their annual report on the affairs of the Company and its subsidiary (together, the "Group"), together with the financial statements and auditor's independent report, for the period from 8 November 2012 to 31 December 2013.

 

Principal activities and investing policy

 

Sherborne Investors (Guernsey) B Limited (the ''Company") is a Guernsey domiciled company incorporated on 8 November 2012 with limited liability. The Company's shares were admitted to trading on AIM on 29 November 2012 and moved from AIM to SFM on 7 May 2013.

 

The Company is a limited partner in SIGB, LP (the "Investment Partnership"), a limited partnership registered in Guernsey on 6 November 2012, holding a 99.98% capital interest. The Company aims to provide investors with capital growth through its investment in the Investment Partnership to which it has committed £200 million, representing substantially all of the Company's net proceeds from its initial public offering. The Company will effect its investment policy indirectly through the Investment Partnership, which seeks to invest in a company (the ''Selected Target Company'') which is publicly quoted, most likely on a UK stock exchange, which it considers to be undervalued as a result of operational deficiencies and which it believes can be rectified by the Investment Manager's active involvement, thereby increasing the value of the investment (a "Turnaround"). The investment will thus not be passive. The Company's investment may be made on-market or off-market.

 

The Group intends that the holding in the Selected Target Company shall not reach such a level as to require the Group to make a bid for the entire Selected Target Company and, therefore, the Group will not have control over the Selected Target Company.

 

The Group's investment policy is to invest in one target company at a time. Therefore, the Group will not seek to reduce risk through diversification. If, after acquiring a shareholding, the share price of the Selected Target Company rises to a level at which further investment and the effort of a Turnaround is, in the Investment Manager's opinion, no longer justified or otherwise no longer presents a viable Turnaround opportunity, the Investment Partnership intends to sell (and distribute the proceeds to the Company) or distribute in kind the holding to the limited partners, rather than seeking to join the Board of Directors or otherwise to engage with the company. In these circumstances, the Company intends to distribute any realised net profits received from the Investment Partnership to the Shareholders. In such event, an amount equal to the Company's capital contribution for the initial Selected Target Company (less any losses on the sale) may be recalled by the Investment Partnership and invested into a new target (a "New Target Company"). This process may be repeated until a Turnaround has been effected.

 

The investment in the Selected Target Company may be in shares but can also be in warrants, convertibles, derivatives and any other equity, debt or other securities. The holding period for the investment in the Selected Target Company is neither fixed nor predictable, but the Company expects that a typical holding period would be greater than one year.

 

Shortly after the offering, the Company's Board of Directors approved a turnaround investment in 3i Group plc ("3i") which was proposed by SIGB, LP's investment manager, Sherborne Investors Management (Guernsey) LLC. During 2013, SIGB, LP acquired approximately 5% of 3i's outstanding shares.

 

In November 2013, the investment manager informed the Company that 3i would no longer be pursued as a turnaround investment. At that time a portion of the investment was sold and the remaining economic exposure of SIGB, LP to 3i shares was offset through the use of derivatives, resulting in an economic net neutral position in 3i shares. The Company declared a dividend of 20 pence per share which was approximately equal to the net profit generated by SIGB, LP on its investment in 3i and which was paid to shareholders in December 2013. Total dividends paid in 2013 totalled £44.0 million, or 21.25 pence per share, representing a 21.25 % return on the gross amount raised in the IPO in November 2012.

 

In January 2014, the residual investment in 37,883,701 shares of 3i held at 31 December 2013, together with derivative securities were subsequently sold, incentive fees paid to the Special Limited Partner and the proceeds of sale returned to the Company pending reinvestment in a New Selected Target Company.

 

Post balance sheet events

 

Details of events that have occurred after the date of the Consolidated Statement of Financial Position are provided in note 13 to the Consolidated Financial Statements.

 

Dividend policy

 

The Company's dividend policy, subject to the discretion of the Directors who reserve the right to retain amounts for working capital, is to pay dividends to Shareholders following receipt of any distributions from the Investment Partnership. This will be dependent on the frequency with which the Selected Target Company pays dividends to its shareholders (of which the Investment Partnership will be one).

 

If dividends are received from the Selected Target Company, the Investment Partnership intends to distribute to its limited partners substantially all of the dividend proceeds after allowing for the Investment Partnership's expenses. The Company, in turn, intends promptly to distribute to Shareholders substantially all of the dividend proceeds after allowing for the Company's expenses.

 

Business review

 

A review of the Company's business during the period and an indication of likely future developments are contained in the Chairman's Statement.

 

Capital

 

Details of the Company's capital are provided in note 10 to the Consolidated Financial Statements. All shares carry equal voting rights.

 

Substantial interests

 

As of 24 March 2014, the Company had received notification of the following material shareholdings:

 

Shareholder

Number of Ordinary

Shares

% of issued share capital

Aviva plc

39,936,400

19.3%

Sherborne Investors GP, LLC

35,000,000

16.9%

Ameriprise Financial, Inc.

31,932,066

15.4%

Invesco Ltd

20,000,000

9.7%

FIL Limited

14,000,000

6.8%

Jupiter Asset Management Limited

13,468,581

6.5%

Ruffer LLP

12,500,000

6.0%

Soros Fund Management LLC

10,000,000

4.8%

Henderson Global Investors Ltd.

9,000,000

4.3%

 

The Directors currently hold no shares in the Company.

 

Dividend

 

The Company has declared and paid total dividends of £43,987,500 during the period.

 

Independent Auditor

 

The Board of Directors elected to appoint Deloitte LLP as auditors to the Company at the inaugural meeting of the Company on 9 November 2012. Deloitte LLP have indicated their willingness to continue as auditors.

 

By order of the Board of Directors

 

Talmai Morgan Christopher Legge

Director Director

 

28 March 2014

 

 

DIRECTORS' REMUNERATION REPORT

 

Remuneration Policy & Components

The Board endeavours to ensure the Remuneration Policy reflects and supports the Company's strategic aims and objectives throughout the period under review. It has been agreed that, due to the small size and structure of the Company, a separate Remuneration Committee would be inefficient; therefore the Board is responsible for discussions regarding remuneration. No external remuneration consultants were appointed during the period under review.

 

As per the Company's Articles of Association, all Directors are entitled to such remuneration as is stated in the Company's Prospectus or as the Company may by ordinary resolution determine; the aggregate overall limit is currently set at £120,000. Subject to this limit, it is the Company's policy to determine the level of Directors' fees, having regard for the level of fees payable to non-executive Directors in the industry generally, the role that individual Directors fulfil in respect of responsibilities related to the Board and Audit Committee and the time dedicated by each Director to the Company's affairs. Base fees are set out below. No increase in non-executive Director fees has been proposed for 2013.

 

Base Fees

2013 £

Chairman

45,000

Audit Committee Chairman

35,000

Non-executive Director

30,000

 

As outlined in the Articles of Association, the Directors may also be paid for all reasonable travelling, hotel and other out-of-pocket expenses properly incurred in the attendance of Board or Committee meetings, General meetings, or meetings with shareholders of the Company or otherwise in discharge of their duties; and all reasonable expenses properly incurred by them seeking independent professional advice on any matter that concerns them in the furtherance of their duties as Directors of the Company.

 

No Director has any entitlement to pensions, paid bonuses or performance fees, granted share options or has been invited to participate in long-term incentive plans. No loans have been taken on behalf of a Director by the Company.

 

None of the Directors has a service contract with the Company. Each of the Directors has entered into a letter of appointment with the Company, subject to election at the first Annual General Meeting, or as determined in line with the Company's Articles, and re-election at subsequent Annual General Meetings in accordance with the Company's Articles and all due regulations and provisions. The Directors do not have any interests in contractual arrangements with the Company or its investment during the period under review, or subsequently. Each appointment can be terminated in accordance with the Company's Articles and without compensation. No notice period is stated in the Articles and is terminable at will of both parties.

 

Directors' and Officers' liability insurance cover is maintained by the Company but is not considered a benefit in kind nor constitutes as part of the Directors' Remuneration. The Company's Articles indemnify each Director, Secretary, agent and officer of the Company, former or present, out of assets of the Company in relation to charges, losses, liabilities, damages and expenses incurred during the course of their duties, in so far as the law allows and provided that such indemnity is not available in circumstances of fraud, wilful misconduct or negligence.

 

Directors' Emoluments

The Directors received the following fees during the period under review:

 

Director

2013 £

2012 £

Talmai Morgan

39,637

4,426

Trevor Ash

34,857

5,068

Ian Brindle 1

22,285

6,516

Christopher Legge 2

19,521

-

Aggregate emoluments

116,300

16,010

 

1 Retired on 7 May 2013

2 Appointed on 10 May 2013

 

 

By order of the Board

 

Ipes (Guernsey) Limited

Company Secretary

28 March 2014

 

 

CORPORATE GOVERNANCE

 

As an unregulated Guernsey incorporated company quoted on the SFM, the Company is not required to comply with the UK Corporate Governance Code or the GFSC Finance Sector Code of Corporate Governance. The Directors, however, place great importance on ensuring that high standards of corporate governance are maintained. Accordingly, the Directors take appropriate measures to ensure that the Company operates with due consideration to any codes of corporate governance which the Board deems appropriate, having regard to the Company's size and nature of business. The Board perceives that good corporate governance practice is necessary for delivering sustainable value, enhance business integrity and to maintain confidence in the Company. To further these aims, the Board has decided to voluntarily comply with the UK Corporate Governance Code dated September 2012 (the "Code"), which sets out guidance in the form of principles and provisions for companies to follow good corporate governance practice. Further information on the Code can be obtained from www.frc.org.uk.

 

The Board is of the view that throughout the period to 31 December 2013, the Company has been compliant with the Code's provisions, on a comply or explain basis. Key issues affecting the Company's corporate governance responsibilities, how they are addressed by the Board and application of the Main Principles of the Code is provided below.

 

Section A: Leadership

The Chairman is responsible for the leadership of the Board and ensuring its effectiveness on all aspects of its role.

 

Board Responsibilities

The Board ensures that the Company's contracts of engagement with the Investment Manager, Administrator and other service providers are operating satisfactorily so as to ensure the safe and accurate management and administration of the Company's affairs and business and that they are competitive and reasonable for Shareholders. Terms of Reference that contain a formal schedule of matters reserved for the Board of Directors and its duly authorised Committee for decision has been approved and can be reviewed at the Company's registered office.

 

Management of the Investment Partnership is the responsibility of Sherborne Investors (Guernsey) GP, LLC, the General Partner, which has delegated investment decisions and day-to-day management of the Investment Partnership to the Investment Manager under the terms of an investment management agreement. Through its majority interest in the Investment Partnership, the Company and therefore the Board, has the ability to approve proposed investments and to remove the General Partner. The performance of the Investment Manager is subject to regular review by the Board.

 

Other matters for the Board include review of the Company's overall strategy and business plans; approval of the Company's half-yearly and annual Financial Statements; review and approval of any alteration to the Group's accounting policies or practices and valuation of investments; approval of any alteration to the Company's capital structure; approval of dividend policy; appointments to the Board and constitution of Board Committees; and performance review of key service providers.

 

The Company holds appropriate Directors' and Officers' Liability Insurance cover in respect of any legal action taken against the Board.

 

Board Composition

The Board consists of three non-executive members. For further information relating to the Board can be found in the Directors' biographies.

 

Board Committees

The Board has established an Audit Committee composed of all members of the Board, all of which are independent. The Chairman of the Board is included as a Committee member to enable a full understanding of the issues facing the Company, but would not be appointed as its Chair. The Committee, its membership and its terms of reference are kept under regular review by the Board.

 

It is intended that the chairmanship of the Audit Committee will be rotated annually among the Directors that are independent of the Investment Manager, except for the Chairman of the Company who may not be selected for this role to avoid unfettered powers of decision. The Chairman of the Audit Committee for the period to 31 December 2013 was Trevor Ash. Christopher Legge assumed the role for the year ending 31 December 2014.

 

The Audit Committee meets at least twice a year and is responsible for ensuring that the financial performance of the Company is properly reported on and monitored, including reviews of the annual and interim accounts, results announcements, internal control systems and procedures and accounting policies.

 

The Audit Committee considers the scope and effectiveness of the Company's external audit. The Company's auditor, Deloitte LLP may also provide additional non-audit services to the Company, which in the Audit Committee's opinion, will not compromise the independence of Deloitte LLP's audit team. Further information is provided in the Report of the Audit Committee.

 

Board and Committee Meeting Attendance

The Board met ten times during the period. Individual attendance at Board and Committee meetings is set out below.

 

 

 

Board

Audit Committee

Talmai Morgan

10

2

Trevor Ash

10

2

Christopher Legge

5

2

Ian Brindle

2

0

Total Meetings for Period

10

2

 

Division of Responsibilities

There are no executive directors appointed to the Board. The non executive director's responsibilities are clearly defined within the Schedule of Matters reserved to the Board. All day-to-day functions are outsourced to external Service Providers.

 

The Chairman

Appointed to the position of Chairman of the Board on 7 May 2013, Talmai Morgan is responsible for leading the Board in all areas, including determination of strategy, organising the Board's business and ensuring the effectiveness of the Board and individual Directors. He also endeavours to produce an open culture of debate within the Board.

 

Role of the non-executive Directors

The Board is composed entirely of non-executive Directors, who meet as required without the presence of the investment manager and service providers to scrutinise the achievement of agreed goals and objectives, and monitor performance. Through the Audit Committee, they are able to ascertain the integrity of financial information and confirm that all financial controls and risk management systems are robust. In addition, a non-executive Director may provide a written statement outlining any concerns to the Chairman upon resignation.

 

See the statements on Board and Committee responsibilities for further information.

 

Section B: Effectiveness

The Board believes that the balance of skills, experience and knowledge, provides for a sound base from which the interest of investors will be served to a high standard.

 

Board Composition & Independence

For the purposes of assessing compliance with the UK Corporate Governance Code, the Board considers the Directors are independent of the Investment Manager and free from any business or other relationship that could materially interfere with the exercise of their independent judgment.

 

Composition of the Board is explained in Section A of the Corporate Governance Report.

 

Board Appointments Process

Appointment Process

There is currently no Nominations Committee for the Company as it is deemed that the size, composition and structure of the Company would mean the process would be inefficient and counter-productive.

 

The Board has chosen not to adopt a definitive policy with quantitative targets for Board diversity. However, gender, knowledge, skills, experience, residency and governance credentials are all considered by the Board when proposing new appointments and in formulating succession plans.

 

Commitment

Chairman's Commitment

Prior to the Chairman's appointment, discussions were undertaken to ensure the Chairman was sufficiently aware of the time needed for his role, and agreed to upon signature of his appointment letter. Other significant commitments of the Chairman were disclosed prior to appointment to the Board, and any changes declared as and when they arise. These commitments, and their subsequent impact, can be identified in his biography.

 

Non-executive Directors' Commitments

The terms and conditions of appointment for non-executive Directors are outlined in their letters of appointment, and are available for inspection by any person at the Company's registered office during normal business hours and at the AGM for fifteen minutes prior to and during the meeting. As with the Chairman, significant appointments are declared prior to appointment, any changes reported as and when appropriate, identified within their biographies and the impact explained.

 

Development

The Board believes that the Company's directors should develop their skills and knowledge through participation at relevant courses. The Chairman is responsible for reviewing and discussing the training and development of each Director according to identified needs. Upon appointment, all Directors participate in discussions with the Chairman and other Directors to understand the responsibilities of the Directors, in addition to the Company's business and procedures. The Company also provides regular opportunities for the Directors to obtain a thorough understanding of the Company's business by regularly meeting members of the senior management team from the investment manager and other service providers, both in person and by phone.

 

Information and Support

Information Provided to the Board

Reports and papers, containing relevant, concise and clear information, are provided to the Board and Committees in a timely manner to enable review and consideration prior to both scheduled and ad-hoc specific meetings. This ensures that Directors are capable of contributing to, and validating, the development of Company strategy and management. The regular reports also provide information that enables scrutiny of the Company's, Investment Manager's and other service providers' performance. When required, the Board has sought further clarification of matters with the Investment Manager and other service providers, both in terms of further reports and via in-depth discussions, in order to make a more informed decision for the Company.

 

Company Secretary

Under the direction of the Chairman, the Company Secretary facilitates the flow of information between the Board, Committees, Investment Manager and other service providers' through the development of comprehensive meeting packs, agendas and other media.

 

Full access to the advice and services of the Company Secretary is available to the Board; in turn, the Company Secretary is responsible for advising on all governance matters through the Chairman. The Articles and schedule of matters reserved for the Board indicate the appointment and resignation of the Company Secretary is an item reserved for the full Board. A review of the performance of the Company Secretary is undertaken by the Board on a regular basis.

 

Evaluation

Board and Director Evaluation

Using a pre-determined template based on the Code's provisions as a basis for review, the Board undertakes an evaluation of its performance and that of the Audit Committee. Additionally, an evaluation focusing on individual commitment, performance and contribution of each Director is conducted. The Chairman meets with each Director to fully understand their views of the Company's strengths and to identify potential weaknesses. If appropriate, new members are proposed to resolve the perceived issues, or a resignation sought. Following discussions and review of the Chairman's evaluation by the other Directors, the Audit Committee Chairman will review the Chairman's performance.

 

Given the Company's size and the structure of the Board, no external facilitator or independent third party is used in the performance evaluation.

 

Re-election

Each Director is required to be elected by shareholders at the first Annual General Meeting following his initial appointment to the Board. The Board recommends the on-going re-election of each Director and supporting biographies, including length of service, are disclosed earlier in this report.

 

Section C: Accountability

The Directors' Responsibility Statement confirms that the financial statements, prepared in accordance with the applicable set of accounting standards, give a true and fair view of the assets, liabilities, financial position and profit or loss of the company as a whole, whilst the Chairman's Statement includes a fair view of the development and performance of the business and the position of the Company.

 

Financial and Business Reporting

Financial and Business Information

An explanation of the Directors' roles and responsibilities in preparing the Annual Report and Accounts for the period to 31 December 2013 is provided in the Report of the Directors.

 

Further information enabling shareholders to assess the Company's performance, business model and strategy can be sourced in the Chairman's Statement and the Report of the Directors.

 

Going concern

After making enquiries and based on the substantial cash reserves as at 31 December 2013, the Directors are of the opinion that the Group has adequate resources to continue its operational activities for the foreseeable future. The Board is therefore of the opinion that the going concern basis should be adopted in the preparation of the Consolidated Financial Statements.

 

Investment Manager

After careful consideration of Sherborne Investment Management (Guernsey) LLC ("SIMG") performance, primarily in terms of advice, managing the portfolio and communicating effectively with stakeholders, the Board agreed that it would be in the best interests of the Company that SIMG continue on the agreed contractual terms.

 

Risk Management and Risk Control

The Board is required to annually review the effectiveness of the Company's key internal controls such as financial, operational and compliance controls and risk management. As this is the Company's first year of operations, the Board has documented these controls and intends to review their effectiveness in the next accounting period. The controls are designed to ensure that the risk of failure to achieve business objectives is managed rather than eliminated, and are intended to provide reasonable, rather than absolute, assurance against material misstatement or loss. Through regular meetings and meetings of the Audit Committee, the Board seeks to maintain full and effective control over all strategic, financial, regulatory and operational issues. The Board maintains an organisational and committee structure with clearly defined lines of responsibility and delegation of authorities.

 

The Company's system of internal control includes inter alia the overall control exercise, procedures for the identification and evaluation of business risk, the control procedures themselves and the review of these internal controls by the Audit Committee on behalf of the Board. Each of these elements that make up the Company's system of internal control is explained in further detail as follows:

 

(i) Control environment

The Company is ultimately dependent upon the quality and integrity of the staff and management of both its Investment Manager, Sherborne Investors Management (Guernsey) LLC, and Fund Administration & Company Secretarial service provider, Ipes (Guernsey) Limited. In each case, qualified and able individuals have been selected at all levels. The staff of both the Investment Manager and Administrator, are aware of the internal controls relevant to their activities and are also collectively accountable for the operation of those controls. Appropriate segregation and delegation of duties is in place. The Audit Committee undertakes a review of the Company's financial controls on a regular basis.

 

In its role as a third-party fund administration services provider, the Ipes Group, of which Ipes (Guernsey) Limited is a part, produces an annual AAF 01/06 Assurance Report on the internal control procedures in place within the Group.

 

(ii) Identification and evaluation of business risks

Another key business risk is the performance of the Company's investment. This is managed by the Investment Manager, who undertakes regular analysis and reporting of business risks in relation to the target company, who then propose appropriate courses of action to the Board for their review.

 

(iii) Key procedures

In addition to the above, the Board's key procedures involve a comprehensive system for reporting financial results to the Board regularly. As this is the Company's first year of operations, the Board has documented these procedures and intends to review their effectiveness in the next accounting period. A review of controls will be conducted by the Audit Committee annually, and a twice-yearly review of investment valuations by the Board, including reports on the underlying investment performance.

 

Due to the size and nature of the Company and the outsourcing of key services to the Administrator and Investment Manager, the Company does not have an internal audit function. It is the view of the Board that the controls in relation to the operating, accounting, compliance and IT risks performed robustly throughout the year. In addition, all have been in full compliance with the various policies and external regulations, including:

 

§ Investment policy, as outlined in the IPO documentation

§ Personal Account Dealing, as outlined in the Model Code

§ Whistleblowing Policy

§ Anti-Bribery Policy

§ Applicable Financial Conduct Authority Regulations

§ Treatment and handling of confidential information

§ Conflicts of interest

§ Compliance policies

 

There were no protected disclosures made pursuant to the whistleblowing policy of service providers in relation to the Company, during the period to 31 December 2013.

 

In summary, the Board considers that the Company's existing internal controls, coupled with the analysis of risks inherent in the business models of the Company and its subsidiaries, continue to provide appropriate tools for the Company to monitor, evaluate and mitigate its risks.

 

Audit Committee and Auditors

Audit Committee Responsibilities

The Audit Committee is intended to assist the Board in discharging its responsibilities for the integrity of the Company's financial statements, as well as aid the assessment of the Company's internal control effectiveness and objectivity of external auditors. Further information on the Committee's responsibilities are given in the Report of the Audit Committee.

 

As previously indicated, all Directors are members of the Committee, and the Board perceives that all have sufficient recent and relevant financial experience. Trevor Ash served as Committee Chairman for 2013; Christopher Legge will serve in this role for 2014.

 

The Committee met twice during 2013 (2012: nil); meeting attendance record is displayed within the Corporate Governance declarations. The Company Secretary acts as the secretary to the Committee.

 

Audit Committee Terms of Reference are available at the registered office upon request.

 

Owing to the size and structure of the Company, there is no internal audit function. The Committee has reviewed the need for an internal audit function, and perceived that the internal control systems in place within Sherborne and its service providers, as evidenced by the internal control reports provided by the providers, give sufficient assurance that a sound system of internal control is maintained that safeguards shareholders' investment and Company assets.

 

Section D: Remuneration

Level and Components of Remuneration

Directors are paid in accordance with agreed principles aimed at focusing on long-term performance of the Company. Further information can be sourced in the Directors' Remuneration Report.

 

Procedures

The Company has a formal remuneration policy, outlined in the Directors' Remuneration Report.

 

Section E: Relations with Shareholders

Dialogue with Shareholders

The Directors place a great deal of importance on communication with shareholders. The Company's Chairman, Investment Manager and Broker aim to meet with large shareholders at least annually. The Board also receives reports from the Brokers on shareholder issues. The Annual Report and Financial Statements are widely distributed to other parties who have an interest in the Company's performance, and are available on the Company's website.

 

All Directors are available for discussions with the shareholders, in particular the Chairman and the Audit Committee Chairman, as and when required.

 

Constructive Use of the AGM

The Notice of AGM is sent out at least 20 working days in advance of the meeting. All shareholders have the opportunity to put questions to the Board or Manager, either formally at the Company's Annual General Meeting on 6 May 2014, informally following the meeting, or in writing at any time during the year via the Company Secretary. The Company Secretary is available to answer general shareholder queries at any time throughout the year.

 

By order of the Board

 

Talmai Morgan

Chairman, 28 March 2014

 

1 Royal Plaza, Royal Avenue,

St Peter Port, Guernsey GY1 2HL

 

 

REPORT OF THE AUDIT COMMITTEE

 

The Board is supported by the Audit Committee, which comprised all the Directors during the period; including the Chairman of the Board to enable a greater understanding of the issues facing the Company. The Board has considered the composition of the Committee and is satisfied that there are sufficient recent relevant skills and experience.

 

Role and Responsibilities

The primary role and responsibilities of the Audit Committee are outlined in the Committee's Terms of Reference, available at the registered office, including:

 

§ Monitoring the integrity of the financial statements of the Company and any formal announcement relating to the Company's financial performance, and reviewing significant financial reporting judgements contained within said statements and announcements;

§ Reviewing the Company's internal financial controls, and the Company's internal control and risk management systems;

§ Monitoring the need for an internal audit function annually;

§ Monitoring and reviewing the independence, objectivity and effectiveness of the external auditors, taking into consideration relevant regulatory and professional requirements;

§ Making recommendations to the Board in relation to the appointment, re-appointment and removal of the external auditors and approving their remuneration and terms of engagement, which in turn can be placed to the shareholders for their approval at the Annual General Meeting;

§ Development and implementation of the Company's policy on the provision of non-audit services by the external auditors, as appropriate;

§ Reviewing the arrangements in place to enable Directors and staff of service providers to, in confidence, raise concerns about possible improprieties in matters of financial reporting or other matters insofar as they may affect the Company;

§ Providing advice to the Board on whether the annual financial statements, taken as a whole, are fair, balanced and understandable and provide the information necessary for shareholders to assess the Company's performance, business model and strategy; and

§ Reporting to the Board on how the Committee discharged all relevant responsibilities, undertaken by myself at each Board meeting.

 

The Committee met twice during the period under review; individual attendance of Directors is outlined on page 10. The main matters discussed at those meetings were:

 

§ Review and approval of the annual audit plan of the external auditors;

§ Discussion and approval of the fee for the external audit;

§ Detailed review of the Half Year Report and Accounts and recommendation for approval by the Board;

§ Discussion of reports from the external auditors following their interim review;

§ Review and approval of the interim review plan of the external auditors;

§ Review of auditor independence;

§ Assessment of the effectiveness of the external audit process as described below;

§ Review of the Company's key risks and internal controls; and

§ Consideration of the 2012 UK Corporate Governance Code, Guidance on Audit Committees and other regulatory guidelines, and the subsequent impact upon the Company.

 

The Committee has also reviewed and considered the whistleblowing policy in place for the Administrator, and is satisfied the relevant staff can raise concerns in confidence about possible improprieties in matters of financial reporting or other matters insofar as they may affect the Company.

 

Significant Risks in Relation to the Financial Statements

Throughout the period, the Audit Committee identified a number of significant issues and areas of key audit risks in respect of the Annual Report and Financial Statements. The Committee reviewed the external audit plan at an early stage and concluded that the appropriate areas of audit risk relevant to the Company had been identified and that suitable audit procedures had been put in place to obtain reasonable assurance that the financial statements as a whole would be free of material misstatements. The table below sets out the key areas of risk identified and how the Committee addressed the issues.

 

Significant Issues

Actions to Address Issue

Valuation and ownership of investment and equity swaps - focus upon one target company means that any errors in valuation can be highly material.

The Audit Committee and Board review detailed portfolio valuations on a regular basis throughout the period under review, and receive confirmation from the Investment Manager that the pricing basis is appropriate and in line with relevant accounting standards.

 

Calculation of fees to related parties - fees paid to investment manager and administrator may be materially misstated.

The Audit Committee reviewed the calculations of fees to ensure no material misstatements. Regular review and comparison of the LPA and Administration Agreement are undertaken to ensure that all fees are as contractually stated. Board approval of all invoices also reduces this risk.

 

Auditor Tenure and Objectivity

The Company's current auditors, Deloitte LLP, have acted in this capacity since the Company's inaugural meeting on 9 November 2012. The Committee reviews the auditor's performance on a regular basis to ensure the Company receives an optimal service. Subject to annual appointment by shareholder approval at the Annual General Meeting, the appointment of the auditor is formally reviewed by the Committee on an annual basis. The Auditors are required to rotate the audit partner regularly every 5 years, and the current partner has been in place since the Company's launch. The Committee has also been advised that the audit partner will rotate for 2014. The Audit Committee intends to undertake a formal review of the external auditor for the year ending 31 December 2014.

 

Deloitte LLP regularly updates the Committee on the rotation of audit partners, staff, level of fees in proportion to overall fee income of the Company, details of any relationships between the auditor, the Company and any target company, and also provides overall confirmation from the auditors' of their independence and objectivity. There are no contractual obligations that restrict the Company's choice of auditors.

 

As this is the Company's first year of operations, this is the first audit process that the Company has conducted, therefore the effectiveness of the audit process will be evaluated once it is complete.

 

The Auditor has provided other services in relation to the Company being listed on AIM and subsequent migration from AIM to SFM. Any non-audit work has been reviewed by the Committee and approved by the Committee Chairman prior to the auditors undertaking any work.

 

As a result of their review, the Committee is satisfied that Deloitte LLP is independent of the Company, the Investment Manager and other service providers and recommends the continuing appointment of the auditors to the Board.

 

Conclusions in Respect of the Financial Statements

The production and the audit of the Company's Annual Report and Financial Statements is a comprehensive process requiring input from a number of different contributors. In order to reach a conclusion on whether the Company's financial statements is fair, balanced and understandable, the Board has requested that the Committee advise on whether it considers that the Annual Report and Financial Statements fulfils these requirements. In outlining their advice, the Committee has considered the following:

 

· The comprehensive documentation that is in place outlining the controls in place for the production of the Annual Report, including the verification processes in place to confirm the factual content;

· The detailed reviews undertaken at various stages of the production process by the investment manager, administrator, auditors and the Committee that are intended to ensure consistency and overall balance;

· The controls enforced by the investment manager, administrator and other third party service providers to ensure complete and accurate financial records and security of the Company's assets; and

 

As a result of the work performed, the Committee has concluded that the Annual Report for the period 8 November 2012 to 31 December 2013, taken as a whole, is fair, balanced and understandable and provides the information necessary for shareholders to assess the Company's performance, business model and strategy, and has reported on these findings to the Board. The Board's conclusions in this respect are set out in the Statement of Directors' Responsibilities.

 

Christopher Legge

Audit Committee Chairman

28 March 2014

 

 

STATEMENT OF DIRECTORS' RESPONSIBILITIES

 

The directors are responsible for preparing the Annual Report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors are required to prepare the group financial statements in accordance with International Financial Reporting Standards (IFRSs) as adopted by the European Union. Under company law the directors must not approve the accounts unless they are satisfied that they give a true and fair view of the state of affairs of the Group and of the profit or loss of the Group for that period. In preparing these financial statements, International Accounting Standard 1 requires that directors:

 

• properly select and apply accounting policies;

• present information, including accounting policies, in a manner that provides relevant, reliable, comparable and understandable information;

• provide additional disclosures when compliance with the specific requirements in IFRSs are insufficient to enable users to understand the impact of particular transactions, other events and conditions on the Group's financial position and financial performance; and

• make an assessment of the Group's ability to continue as a going concern.

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the Group's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies (Guernsey) Law, 2008. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

 

The directors are responsible for the maintenance and integrity of the corporate and financial information included on the company's website. Legislation in Guernsey governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

 

Responsibility statement

We confirm that to the best of our knowledge:

• the financial statements, prepared in accordance with International Financial Reporting Standards, give a true and fair view of the assets, liabilities, financial position and profit or loss of the company and the undertakings included in the consolidation taken as a whole;

• the Chairman's statement, Directors' report and Corporate Governance statement include a fair review of the development and performance of the business and the position of the Company and the undertakings included in the consolidation taken as a whole, together with a description of the principal risks and uncertainties that they face; and

• the annual report and financial statements, taken as a whole, are fair, balanced and understandable and provide the information necessary for shareholders to assess the Company's performance, business model and strategy.

 

In accordance with section 249 of the Companies (Guernsey) Law, 2008, each of the Directors confirms that, to the best of their knowledge:

 

• There is no relevant audit information of which the Company's auditors are unaware;

• All Directors have taken the necessary steps that they ought to have taken to make themselves aware of any relevant audit information and to establish that the auditors are aware of said information.

 

For Sherborne Investors (Guernsey) B Limited

 

Talmai Morgan

Chairman

28 March 2014

 

 

INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF

SHERBORNE INVESTORS (GUERNSEY) B LIMITED

 

Opinion on financial statements of Sherborne Investors (Guernsey) B Limited

In our opinion the financial statements:

· give a true and fair view of the state of the Group's affairs as at 31 December 2013 and of its profit for the period from 8 November 2012 to 31 December 2013;

· have been properly prepared in accordance with International Financial Reporting Standards (IFRSs) as adopted by the European Union; and

· have been prepared in accordance with the requirements of The Companies (Guernsey) Law, 2008.

 

The financial statements comprise the Consolidated Statement of Comprehensive Income, the Consolidated Statement of Financial Position, the Consolidated Statement of Changes in Equity, the Consolidated Statement of Cash Flows, and the related notes 1 to 15. The financial reporting framework that has been applied in their preparation is applicable law and IFRSs as adopted by the European Union.

 

 

 

Going concern

We have reviewed the Directors' statement contained within the Corporate Governance Report that the Group is a going concern. We confirm that:

we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate; and

we have not identified any material uncertainties that may cast significant doubt on the group's ability to continue as a going concern.

 

However, because not all future events or conditions can be predicted, this statement is not a guarantee as to the group's ability to continue as a going concern.

 

Our assessment of risks of material misstatement

The assessed risks of material misstatement described below are those that had the greatest effect on our audit strategy, the allocation of resources in the audit and directing the efforts of the engagement team:

 

Risk

How the scope of our audit responded to the risk

Valuation of investments and derivatives

During November 2013 the Group offset its remaining investment in 3i Group Plc through the use of derivatives. Investments and derivatives should be recorded at fair value through profit or loss. The risk exists that the investment and related derivatives are not accurately valued based on relevant information that is representative of their fair value leading to a material misstatement.

As part of our work, and to address the risk of incorrect valuation of the derivatives, we agreed the equity holdings as at the period-end to an independent custody and counterparty confirmation and agreed the year end valuation to an independent source. The initial cost of the investment was also tested to enable us to assess whether the unrealised gain as at 31 December 2013 had been determined appropriately.

We also agreed details of the forward contracts to independent counterparty confirmations and recalculated the mark to market value of the derivatives based on independent inputs.

Classification of Investment and Calculation of Incentive Fees

The incentive fee calculation is dependent upon whether the investment is classified a Turnaround or Stake Building investment. The risk is that the calculation is on the wrong basis, leading to a material misstatement.

 

We have assessed whether it is appropriate to treat the investment as a Stake Building investment at the year end by reviewing the terms of the Amended and Restated Limited Partnership Agreement.

We then performed a recalculation of the incentive fee. We have reviewed the notes to the financial statements to assess whether there is adequate disclosure of the incentive fee in the financial statements and we have also considered whether we agree with the classification of the incentive fee as a reallocation of retained earnings to the Non-Controlling Interest rather than an expense.

 

The Audit Committee's consideration of these risks is set out in the Report of the Audit Committee.

 

Our audit procedures relating to these matters were designed in the context of our audit of the financial statements as a whole, and not to express an opinion on individual accounts or disclosures. Our opinion on the financial statements is not modified with respect to any of the risks described above, and we do not express an opinion on these individual matters.

 

An overview of the scope of our audit

 

 Sherborne Investors (Guernsey) B Limited ("the Company") is a limited partner in SIGB LP ("the Investment Partnership"), together "the Group", holding a 99.98% capital interest. The Investment Partnership holds the underlying investment in 3i Group Plc. Deloitte LLP have audited both the Group and the Investment Partnership and therefore the audit team have audited the whole Group directly.

 

 

Our application of materiality

 

We define materiality as the magnitude of misstatement in the financial statements that makes it probable that the economic decisions of a reasonably knowledgeable person would be changed or influenced. We use materiality both in planning the scope of our audit work and in evaluating the results of our work.

 

We determined materiality for the Group to be £4,145,000, which is approximately 2% of equity. The Company's investment objective is to realise capital growth therefore equity is the key benchmark for shareholders.

 

We agreed with the Audit Committee that we would report to the Committee all audit differences in excess of £82,500, as well as differences below that threshold that, in our view, warranted reporting on qualitative grounds. We also report to the Audit Committee on disclosure matters that we identified when assessing the overall presentation of the financial statements.

 

Matters on which we are required to report by exception

 

Adequacy of explanations received and accounting records

Under the Companies (Guernsey) Law, 2008 we are required to report to you if, in our opinion:

· we have not received all the information and explanations we require for our audit; or

· proper accounting records have not been kept by the parent company; or

· the financial statements are not in agreement with the accounting records.

 

We have nothing to report in respect of these matters.

 

Our duty to read other information in the Annual Report

Under International Standards on Auditing (UK and Ireland), we are required to report to you if, in our opinion, information in the annual report is:

· materially inconsistent with the information in the audited financial statements; or

· apparently materially incorrect based on, or materially inconsistent with, our knowledge of the Group acquired in the course of performing our audit; or

· otherwise misleading.

 

In particular, we are required to consider whether we have identified any inconsistencies between our knowledge acquired during the audit and the directors' statement that they consider the annual report is fair, balanced and understandable and whether the annual report appropriately discloses those matters that we communicated to the audit committee which we consider should have been disclosed. We confirm that we have not identified any such inconsistencies or misleading statements.

 

Respective responsibilities of directors and auditor

As explained more fully in the Directors' Responsibilities Statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view. Our responsibility is to audit and express an opinion on the financial statements in accordance with applicable law and International Standards on Auditing (UK and Ireland). Those standards require us to comply with the Auditing Practices Board's Ethical Standards for Auditors. We also comply with International Standard on Quality Control 1 (UK and Ireland). Our audit methodology and tools aim to ensure that our quality control procedures are effective, understood and applied. Our quality controls and systems include our dedicated professional standards review team and independent partner reviews.

 

This report is made solely to the Company's members, as a body, in accordance with section 262 of the Companies (Guernsey) Law, 2008. Our audit work has been undertaken so that we might state to the Company's members those matters we are required to state to them in an auditor's report and/or those further matters we have expressly agreed to report to them on in our engagement letter and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the Company's members as a body, for our audit work, for this report, or for the opinions we have formed.

 

Scope of the audit of financial statements

 

An audit involves obtaining evidence about the amounts and disclosures in the financial statements sufficient to give reasonable assurance that the financial statements are free from material misstatement, whether caused by fraud or error. This includes an assessment of: whether the accounting policies are appropriate to the Group's circumstances and have been consistently applied and adequately disclosed; the reasonableness of significant accounting estimates made by the directors; and the overall presentation of the financial statements. In addition, we read all the financial and non-financial information in the Annual Report to identify material inconsistencies with the audited financial statements and to identify any information that is apparently materially incorrect based on, or materially inconsistent with, the knowledge acquired by us in the course of performing the audit. If we become aware of any apparent material misstatements or inconsistencies we consider the implications for our report.

 

Richard Anthony Garrard FCA

for and on behalf of Deloitte LLP

Chartered Accountants and RecognisedAuditor

St Peter Port, Guernsey

28 March 2014

 

 

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

For the period from 8 November 2012 to 31 December 2013

 

8 November 2012 to

31 December 2013

Notes

£

£

Income

1(e)

Unrealised gain on investments held at fair value through profit or loss

1(d), 5

19,126,162

Realised gain on investments and derivative contracts

5

27,521,380

Dividend income

5,153,178

Bank interest income

228,980

52,029,700

Expenses

1(f)

Professional fees

876,983

Trading and custodian fees

1,348,207

Administrative fees

284,095

Other fees

142,389

Management fees

14

1,438,278

Non-recurring expenses*

273,536

Directors' fees

2

132,310

(4,495,798)

Consolidated comprehensive income for the period

47,533,902

Income attributable to:

Shareholders

37,593,790

Non-controlling interest

1(b), 14

9,940,112

Weighted average number of shares outstanding

207,000,000

Basic and diluted gain per share (pence)

4

18.16

All revenue and expenses are derived from continuing operations.

*Non-recurring expenses relate to the total costs associated with the migration from AIM to SFM.

The accompanying notes form an integral part of these consolidated financial statements.

 

 

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

As at 31 December 2013

 

31 December 2013

Notes

£

£

Non-current Assets

Financial assets at fair value through profit or loss

5

135,394,351

135,394,351

Current Assets

Prepaid expenses

6

47,849

Income receivable

7

2,538,766

Cash and cash equivalents

8, 15

69,519,409

72,106,024

Current Liabilities

Trade and other payables

9

(91,630)

Net Current Assets

72,014,394

Net Assets

£

207,408,745

Capital and Reserves

Called up share capital and share premium

10

203,833,343

Retained earnings

(6,393,710)

Equity attributable to the Company

197,439,633

Non-controlling interest

1(l), 14

9,969,112

Total Equity

£

207,408,745

 

 

The Consolidated Financial Statements were approved by the Board of Directors for issue on 28 March 2014.

 

Signed on behalf of the Board

 

Talmai Morgan Christopher Legge

Director Director

 

The accompanying notes form an integral part of these consolidated financial statements.

 

 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

For the period from 8 November 2012 to 31 December 2013

 

 

Share Capital

and Share

Premium

Retained

Reserves

Non-

Controlling

Interest

Total

Equity

Notes

£

£

£

£

Balance at 8 November 2012

-

-

-

-

Issue of share premium

10

207,000,000

-

-

207,000,000

Investment by non-controlling interest

1(b)

-

-

29,000

29,000

Cost of share issue

10

(3,166,657)

-

-

(3,166,657)

Total comprehensive income for the period

-

47,523,970

9,932

47,533,902

Incentive allocation

14,1(l)

-

(9,930,180)

9,930,180

-

Dividends

12

-

(43,987,500)

-

(43,987,500)

Balance at 31 December 2013

203,833,343

(6,393,710)

9,969,112

207,408,745

 

The accompanying notes form an integral part of these consolidated financial statements.

 

 

CONSOLIDATED STATEMENT OF CASH FLOWS

For the period from 8 November 2012 to 31 December 2013

 

Notes

8 November 2012 to

31 December 2013

£

Net cash flow used in operating activities

(1,608,625)

Investing activities

Purchase of investments

(237,273,671)

Proceeds from disposal of investments

145,828,453

Proceeds from derivatives contracts

2,698,409

Net cash flows used in investing activities

(88,746,809)

Financing activities

Issue of share premium

10

207,000,000

Cost of share issue

10

(3,166,657)

Commitments from non-controlling interest

14

29,000

Dividends paid

12

(43,987,500)

Net cash flows from financing activities

159,874,843

Net increase in cash and cash equivalents

69,519,409

Cash and cash equivalents at beginning of period

-

Cash and cash equivalents at period end

69,519,409

Net cash flow used in operating activities

Total consolidated comprehensive income for the period

47,533,902

Realised gain on investments and derivative contracts

(27,521,380)

Fair value gain on financial assets

(19,126,162)

Increase in prepaid expenses and income receivable

(2,586,615)

Increase in trade and other payables

91,630

Net cash flow used in operating activities

(1,608,625)

 

The accompanying notes form an integral part of these consolidated financial statements.

 

 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the period from 8 November 2012 to 31 December 2013

 

1. Summary of significant accounting policies

 

Reporting entity

 

Sherborne Investors (Guernsey) B Limited (the ''Company") is a closed-ended investment company with limited liability formed under The Companies (Guernsey) Law, 2008. The Company was incorporated and registered in Guernsey on 8 November 2012. The Company commenced dealings on the London Stock Exchange's AIM market on 29 November 2012 and moved from AIM to Specialist Fund Market ("SFM") on 7 May 2013. The Company's registered office is 1 Royal Plaza, Royal Avenue, St Peter Port, Guernsey GY1 2HL. The "Group" is defined as the Company and its subsidiary, SIGB, LP.

 

Basis of preparation

 

The Consolidated Financial Statements of the Group have been prepared in accordance with International Financial Reporting Standards ("IFRS") as adopted by the European Union, which comprise standards and interpretations approved by the International Accounting Standards Board (the "IASB") and International Accounting Standards and Standing Interpretations Committee interpretations approved by the International Accounting Standards Committee (the ''IASC'') that remain in effect, together with applicable legal and regulatory requirements of Guernsey law. The directors of the Company have taken the exemption in Section 244 of The Companies (Guernsey) Law, 2008 (as amended) and have therefore elected to only prepare Consolidated Financial Statements for the period.

 

These Consolidated Financial Statements have been prepared on the historical cost basis, as modified by the measurement at fair value of investments and derivatives.

 

Going concern

 

The Consolidated Financial Statements have been prepared on the going concern basis. The Group currently holds significant cash balances. After making enquiries, and on the strength of its Consolidated Statement of Financial Position, the Directors are of the opinion that the Group has adequate resources to continue its operational activities for the foreseeable future. The Board is therefore of the opinion that the going concern basis should be adopted in the preparation of the Consolidated Financial Statements.

 

Critical accounting judgments and key sources of estimation uncertainty

 

The preparation of the Group's Consolidated Financial Statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and contingencies at the date of the Group's Consolidated Financial Statements and revenue and expenses during the reported period. Actual results could differ from those estimated.

 

As more fully described in Note 14, "Related Party Transactions", the Special Limited Partner is entitled to receive an incentive allocation once aggregate distributions to Partners of the Investment Partnership exceed a certain level. The basis of the incentive calculation differs depending on how the investment in the Selected Target Company is ultimately characterized (i.e as a Turnaround or Stake Building Investment). Otherwise there are no significant estimates utilised for the preparation of the Group's Consolidated Financial Statements as at 31 December 2013 due to the nature of the activities that have occurred in this period, together with the sole investment held by the Group being quoted on the London Stock Exchange. Fair value of financial assets held through profit or loss is therefore based on the quoted closing bid price at 31 December 2013.

 

Adoption of new and revised standards

(i) Amendments early adopted by the Company:

There were no standards, amendments and interpretations adopted early by the Company.

(ii) Standards, amendments and interpretations that are in issue but not yet effective:

 

New Standards

Effective date

IFRS 9

Financial Instruments - Classifications and Measurement

1 January 2018

IFRS 10

Consolidated Financial Statements

1 January 2014

IFRS 11

Joint Arrangements

1 January 2014

IFRS 12

Disclosure of Interests in Other Entities

1 January 2014

IFRS 13

Fair Value Measurement

1 January 2013

 

 

Revised and amended standards

IAS 28

Investments in Associates and Joint Ventures (revised)

1 January 2014

IFRS 7

Disclosures - Offsetting Financial Assets and Financial Liabilities (amended)

1 January 2013

IFRS 8

Aggregation of Segments and Reconciliation of Segment Assets

1 July 2014

IFRS 10

Amendments for Investment Entities

1 January 2014

IFRS 12

Amendments for Investment Entities

1 January 2014

IFRS 13

Scope of Portfolio Exception (amended)

1 July 2014

IAS 24

Management Entities (amended)

1 July 2014

IAS 32

Offsetting Financial Assets and Financial Liabilities (amended)

1 January 2014

IFRS 7/9

Mandatory Effective Date and Transition Disclosure (amended)

1 January 2018

The Directors will consider and assess the impact of IFRS 10 on the Consolidated Financial Statements of the Company in future periods. Unless stated otherwise, the Directors do not consider the adoption of new and revised Accounting Standards and Interpretations to have a material impact.

 

a. Basis of consolidation

 

The Consolidated Financial Statements incorporate the financial statements of the Company and an entity controlled by the Company (its subsidiary). Control is achieved where the Company has the power to govern the financial and operating policies of an investee entity so as to obtain benefits from its activities.

 

Non-controlling interests in the net assets of the consolidated subsidiary are identified separately from the Group's equity therein. Non-controlling interests consist of the amount of those interests at the date of the original business combination and the non-controlling entities' share of changes in equity since the date of the combination. Losses applicable to the non-controlling entities in excess of their interest in the subsidiary's equity are allocated against their interests to the extent that this would create a negative balance.

 

Where necessary, adjustments are made to the financial statements of the subsidiary to bring the accounting policies used into line with those used by the Group.

 

All intra-group transactions, balances and expenses are eliminated on consolidation.

 

The Company owns 99.98% of the capital interest in SIGB, LP. Whilst the general partner of SIGB, LP, Sherborne Investors (Guernsey) GP, LLC, a company registered in Delaware, USA, is responsible for directing the day to day operations of SIGB, LP, the Company, through its majority interest in SIGB, LP, has the ability to approve the proposed investment of SIGB, LP and to remove the general partner. Hence, the Company has consolidated SIGB, LP in its financial statements.

 

b. Business combinations

 

On 22 November 2012, the Company subscribed to commit £200 million (two hundred million pounds) to SIGB, LP (the "Investment Partnership"), a Guernsey limited partnership.

 

The objective of this business combination is for the Investment Partnership to realise capital growth from investment in a selected target company identified by the Investment Manager with the aim of generating a significant capital return for Shareholders.

The interest of non-controlling parties in the acquiree is initially measured at the minority's proportion of the net fair value of the assets, liabilities and contingent liabilities recognised.

 

c. Functional currency

 

Items included in the Consolidated Financial Statements of the Group are measured using the currency of the primary economic environment in which the entity operates ("the functional currency"). The Consolidated Financial Statements are presented in GBP(£), which is the Group's functional and presentational currency. Transactions in currencies other than £ are translated at the rate of exchange ruling at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the date of the Consolidated Statement of Financial position are retranslated into sterling at the rate of exchange ruling at that date. Exchange differences are reported in the Consolidated Statement of Comprehensive Income.

 

d. Financial assets at fair value through profit or loss

 

Investments, including equity and loan investments in associates, are designated as fair value through profit or loss in accordance with International Accounting Standard 39 ("IAS 39") ''Financial Instruments: Recognition and Measurement'', as the Company is an investment company whose business is investing in financial assets with a view to profiting from their total return in the form of interest and changes in fair value. Investments in votings shares and derivative contracts are initially recognised at cost. The investments in voting shares and derivative contracts are subsequently re-measured at fair value, as determined by the Directors. Unrealised gains or losses arising from the revaluation of investments in voting shares and derivative contracts are taken directly to the Consolidated Statement of Comprehensive Income.

Fair Value is determined as follows:

 

Investments measured and reported at fair value are classified and disclosed in one of the following categories:

 

Level I - An unadjusted quoted price in an active market provides the most reliable evidence of fair value and is used to measure fair value whenever available. As required by IFRS 7, the Group will not adjust the quoted price for these investments, even in situations where it holds a large position and a sale could reasonably impact the quoted price.

 

Level II - Inputs are other than unadjusted quoted prices in active markets, which are either directly or indirectly observable as of the reporting date, and fair value is determined through the use of models or other valuation methodologies.

 

Level III - Inputs are unobservable for the investment and include situations where there is little, if any, market activity for the investment. The inputs into the determination of fair value require significant management judgment or estimation.

The investments held by the Group at the period end are classified as meeting the definition of Level I and Level II.

 

e. Revenue recognition

 

Dividend income is recognised when the Group's right to receive payment has been established. Tax suffered on dividend income for which no relief is available is treated as an expense.

Interest receivable from short-term deposits and investment income are recognised on an accruals basis. Where receipt of investment income is not likely until the maturity or realisation of an investment then the investment income is accounted for as an increase in the fair value of the investment.

 

f. Expenses

All expenses are accounted for on an accruals basis. Expenses are charged through the Consolidated Statement of Comprehensive Income.

 

g. Prepaid expenses and trade receivables

 

Trade and other receivables are initially recognised at fair value. A provision for impairment of trade receivables is established when there is objective evidence the Group will not be able to collect all amounts due according to the original terms of the receivables.

 

h. Cash and cash equivalents

 

Cash and cash equivalents comprises cash in hand, call and current balances with banks and similar institutions, which are readily convertible to known amounts of cash and which are subject to insignificant risk of changes in value. This definition is also used for the Consolidated Statement of Cash Flows.

i. Trade and other payables

Trade and other payables are initially recognised at fair value and subsequently, where necessary, re-measured at amortised cost using the effective interest method.

j. Financial instruments

Financial instruments and financial liabilities are recognised in the Group's Consolidated Statement of Financial Position when the Group becomes a party to the contractual provisions of the instrument.

 

k. Segmental reporting

 

As the Group invests in one investee company, there is no segregation between industry, currency or geographical location. No further disclosures have been made in conjunction with IFRS 8 Operating Segments as it is deemed not to be applicable.

 

l. Incentive allocation

The incentive allocation is accounted for on an accruals basis and the calculation is disclosed in Note 14. It was calculated as £9,930,180 at 31 December 2013. The incentive is payable to Non-Controlling Interest and therefore recognised in the Consolidated Statement of Changes in Equity rather than recognised as an expense in the Consolidated Statement of Comprehensive Income.

2. Comprehensive income

 

The consolidated comprehensive income has been arrived at after charging:

8 November 2012

to 31 December 2013

£

Directors' fees

132,310

Auditor's remuneration

52,495

 

In addition to the audit related remuneration above, the following non-audit related fees were paid to the Auditor in the same period:

 

i) A fee of £53,000 for services provided in relation to the Company being listed on AIM. These have been included in share issue costs (see note 10).

ii) A fee of £18,500 for services in relation to the Company's migration from AIM to SFM.

 3. Tax on ordinary activities

 

The Company has been granted exemption from income tax in Guernsey under the Income Tax (Exempt Bodies) (Bailiwick of Guernsey) Ordinance 1989, and is liable to pay an annual fee (currently £600) under the provisions of the Ordinance. As such it will not be liable to income tax in Guernsey other than on Guernsey source income (excluding deposit interest on funds deposited with a Guernsey bank). No withholding tax is applicable to distributions to Shareholders by the Company.

The Investment Partnership will not itself be subject to taxation in Guernsey. No withholding tax is applicable to distributions to partners of the Investment Partnership.

 

Income which is wholly derived from the business operations conducted on behalf of the Investment Partnership with, and investments made in, persons or companies who are not resident in Guernsey will not be regarded as Guernsey source income. Such income will not therefore be liable to Guernsey tax in the hands of non-Guernsey resident limited partners.

 

Dividend income is shown gross of any withholding tax.

 

4. Gain per share

 

The calculation of basic and diluted gain per share is based on the return on ordinary activities less total comprehensive income attributable to the Non-Controlling Interest and on there being 207,000,000shares in issue.

 

5. Financial assets at fair value through profit or loss

As at 31 December 2013

£

Opening fair value at the beginning of the period

-

Purchases at cost

 237,432,115

Disposal at cost

(121,163,926)

Fair value adjustments

29,621,945

Derivative contracts - Mark to market

(10,495,783)

Closing fair value at the end of the period

135,394,351

Percentage holding of 3i

3.89%

In December 2012, the Board approved a Turnaround investment in 3i Group plc ("3i") which was proposed by SIGB, LP's Investment Manager, Sherborne Investors Management (Guernsey) LLC. 3i is a leading international investor focused on mid-market private equity, infrastructure and debt management across Europe, Asia and the Americas. Its shares are listed on the London Stock Exchange.

 

During 2013, SIGB, LP acquired approximately 5% of 3i's outstanding shares.

 

In November 2013, the investment manager informed the Company that 3i would no longer be pursued as a Turnaround investment. At that time a portion of the investment was sold and the remaining economic exposure of SIGB, LP to 3i shares was offset through the use of derivative forward contracts with a nominal value equivalent to the investment of 37,883,701 shares in 3i. The fair value of the contract was £145,890,133 and is shown net of the fair value of the investment above. This resulted in an economic net neutral position in 3i share.

 

The Company declared a dividend of 20 pence per share which was approximately equal to the net profit generated by SIGB, LP on its investment in 3i and which was paid to shareholders in December 2013. Total dividends paid in 2013 totalled £44.0 million, or 21.25 pence per share, representing a 21.25 % return on the gross amount raised in the IPO in November 2012.

 

In January 2014, the residual investment in 37,883,701 shares of 3i held at 31 December 2013, together with derivative securities were subsequently sold, incentive fees paid to the Special Limited Partner and the proceeds of sale returned to the Company pending reinvestment in a New Selected Target Company.

 

6. Prepaid Expenses

 

As at 31 December 2013

£

Prepaid directors and officers insurance

23,507

Other prepaid expenses

24,342

47,849

 

7. Income Receivable

 

As at 31 December 2013

£

Dividend income receivable

2,538,208

Bank interest receivable

 558

2,538,766

 

8. Cash and cash equivalents

 

Cash and cash equivalents comprises cash held by the Group and short term deposits held with various banking institutions. The carrying amount of these assets approximates their fair value.

 

9. Trade and other payables

As at 31 December 2013

£

Other payables

91,630

91,630

 

10. Share capital and share premium

 

As at 31 December 2013

Consolidated

Authorised share capital

No.

Ordinary Shares of no par value

Unlimited

Issued and fully paid

No.

Ordinary Shares of no par value

207,000,000

 

As at 31 December 2013

Consolidated

Share premium account

£

Share premium account upon issue

207,000,000

Less: Costs of issue

(3,166,657)

Balance at the end of the period

203,833,343

 

On 29 November 2012 the Company completed its initial public offering and its shares were admitted to trading on AIM. The share issue of 207 million shares at £1 each raised gross cash proceeds of £207,000,000. Costs associated with the issue were £3,166,657, which are deductible against the share premium reserve. This equates to a cost of £0.015 per share.

 

11. Net asset value per share attributable to the Company

 

No. of Shares

Consolidated Pence per Share

31 December 2013

Ordinary Shares

Basic and diluted

207,000,000

95.38

 

12. Dividend

On 7 August 2013, the Company declared a dividend of 1.25 pence per share which was paid on 6 September 2013 to shareholders on register at 16 August 2013.

 

On 18 November 2013, the Company declared a further dividend of 20.0 pence per share which was paid on 13 December 2013 to shareholders on register at 29 November 2013.

 

13. Events after the balance sheet date

 

On 2 January 2014, the investment in 3i was sold and the derivative contracts terminated, at total realised gain of £45,914,173. Shortly thereafter, net proceeds of £182,388,428 were distributed by SIGB, LP to the Company. This also triggered the payment of an incentive allocation of £9,733,160 to the Special Limited Partner. The net cash proceeds are available for reinvestment in a New Selected Target Company.

 

In December 2013, Sherborne Investors Management (Guernsey) LLC ("SIMG") proposed an investment by SIGB, LP in a New Selected Target Company. The Board of Directors of the Company approved the proposed New Selected Target Company investment and the price up to which SIMG could purchase shares in it. In January 2014, SIGB, LP began to acquire an economic interest in the New Selected Target Company. On 28 February 2014, Electra Private Equity plc ("Electra") released to the market a TR-1 notification from SIMG which stated that as of 25 February 2014, SIGB, LP beneficially held an economic interest in 3,619,114 ordinary shares, or approximately 10.24% of Electra's outstanding shares, represented by a combination of ordinary shares and total return swaps. SIMG has informed the Company that, as at 21 March 2014 SIGB, LP has an economic interest in 6,653,435 ordinary shares or approximately 18.83% of Electra's outstanding shares. Pursuant to its existing authority, SIMG may sell, short or otherwise dispose of all or a part of such shares held in Electra or purchase additional shares at any time.

 

On 28 February 2014, the Company announced a change in Sole Financial Adviser and Corporate Broker from Jefferies International Limited to Numis Securities Limited.

14. Related party transactions

 

The Investment Partnership and its General Partner, Sherborne Investors (Guernsey) GP, LLC, have engaged Sherborne Investors Management (Guernsey) LLC to serve as Investment Manager who is responsible for identifying the Selected Target Company, subject to approval by the Board of Directors of the Company, as well as day to day management activities of the Investment Partnership. The Investment Manager is entitled to receive from the Investment Partnership a monthly management fee equal to one-twelfth of 1% of the net asset value of the Investment Partnership, less cash and cash equivalents and certain other adjustments. At the period end, management fees of £1,438,278 had been paid by the Partnership. No balance was outstanding at the period end.

 

The sole member of Sherborne Investors (Guernsey) GP, LLC is Sherborne Investors LP (the non-controlling interest), which also serves as the Special Limited Partner of the Investment Partnership. The Special Limited Partner is entitled to receive an incentive allocation once aggregate distributions to Partners of the Investment Partnership, of which one is the Company, exceed a certain level of capital contributions to the Investment Partnership, excluding amounts contributed attributable to management fees.

 

For Turnaround investments, the incentive allocation is computed at 10% of the distributions to all Partners in excess of 110%, increasing to 20% of the distributions to all Partners in excess of 150% and increasing to 25% of the distributions to all Partners in excess of 200% of capital contributions, excluding amounts contributed attributable to management fees.

 

If after acquiring a shareholding, the share price of the Selected Target Company rises to a level at which further investment and the effort of a Turnaround is, in the Investment Manager's opinion, no longer justified or otherwise no longer presents a viable Turnaround opportunity, the Investment Partnership intends to sell (and distribute the proceeds to the Company) or distribute in kind the holding to the limited partners (in each case after deductions for any costs and expenses and for the Investment Partnership's Minimum Capital Requirements and subject to applicable law and regulation), rather than seeking to join the Board of Directors or otherwise engage with Selected Target company ( a "Stake Building Investment").

 

For Stake Building Investments, the incentive allocation is computed at 20% of net returns on the investment of the Investment Partnership, such amount to be payable after each partner in the Investment Partnership has had distributed to it an amount equal to its aggregate capital contribution to the Investment Partnership in respect to the Stake Building Investment (excluding any capital contributions attributable to Management Fees). The Special Limited Partner may waive or defer all or any part of any incentive allocation otherwise due.

 

At 31 December 2013, the Company was not pursuing a Turnaround strategy with respect to its investment in 3i, therefore the incentive allocation has been computed based on a Stake Building Investment and amounts to £9,930,180.

Each of the directors (other than the Chairman) receives a fee payable by the Company currently at a rate of £30,000 per annum. The Chairman of the Audit Committee receives £5,000 per annum in addition to such fee. The Chairman receives a fee payable by the Company currently at the rate of £45,000 per annum.

 

Individually and collectively, the Directors of the Company hold no shares of the Company as at 31 December 2013.

 

The General Partner, Sherborne Investors (Guernsey) GP, LLC, subscribed for 35 million shares in addition to the 172 million shares issued in the placing. Subsequent to the offering the Sherborne shares were transferred to affiliate entities.

 

Sherborne Investors GP, LLC has granted to the Company a non-exclusive licence to use the name "Sherborne Investors" in the UK and the Channel Islands in the corporate name of the Company and in connection with the conduct of the Company's business affairs. The Company may not sub-licence or assign its rights under the Trademark Licence Agreement. Sherborne Investors GP, LLC receives a fee of £20,000 per annum for the use of the licensed name.

 

15. Financial risk factors

 

The Group's investment objective is to realise capital growth from investment in the Selected Target Company, identified by the Investment Manager with the aim of generating significant capital return for Shareholders. Consistent with that objective, the Group's financial instruments mainly comprise of an investment in a Selected Target Company. In addition, the Group holds cash and cash equivalents as well as having trade and other receivables and trade and other payables that arise directly from its operations.

Liquidity risk

 

The Group's cash and cash equivalents are placed in demand deposits and short-term money market instruments with a range of financial institutions.

 

The following table details the liquidity analysis for financial liabilities at the date of the Consolidated Statement of Financial Position:

 

As at 31 December 2013

Consolidated

Less than 1 month

1 - 3 months

Total

£

£

£

Trade and other payables

(63,673)

(27,957)

(91,630)

(63,673)

(27,957)

(91,630)

 

Credit risk

 

The Company is exposed to credit risk in respect of its cash and cash equivalents and derivative contracts, arising from possible default of the relevant counterparty, with a maximum exposure equal to the carrying value of those assets. The credit risk on liquid funds is mitigated through the Group depositing cash and cash equivalents across several banks. The credit risk associated with derivative contracts is limited because the counterparty, Credit Suisse International has high-credit ratings assigned by international credit-rating agencies.

 

The Group is exposed to credit risk in respect of its trade receivables and other receivable balances with a maximum exposure equal to the carrying value of those assets.

 

Market risk

 

Market price risk arises as a result of the Group's exposure to the future values of the share price of the Selected Target Company. It represents the potential loss that the Group may suffer through investing in the Selected Target Company. Whilst the Group was exposed to market price risk during the year, the Group has mitigated the risk of exposure to price movement of its investment in the Selected Target Company at period end by entering into derivative contracts equivalent to the exposure in 3i. As at the period end there was no market price risk.

 

Interest rate risk

 

The Group is subject to risks associated with changes in interest rates in respect of interest earned on its cash and cash equivalents. The Group seeks to mitigate this risk by monitoring the placement of cash balances on an ongoing basis in order to maximize the interest rates obtained. This risk is also mitigated through the Group depositing cash and cash equivalents across several banks.

 

As at 31 December 2013

Interest bearing

Less than

1 month

1 month to

3 months

3 months to

1 year

Non- interest bearing

Total

£

£

£

£

£

Assets

Cash and cash equivalents

69,519,409

-

-

-

69,519,409

Investments held at fair value through profit or loss

-

-

-

135,394,351

135,394,351

Income receivable

-

-

-

2,538,766

2,538,766

Prepaid expenses

-

-

47,849

47,849

Total Assets

69,519,409

-

-

137,980,966

207,500,375

Liabilities

Other payables

-

-

-

(91,630)

(91,630)

Total Liabilities

-

-

-

(91,630)

(91,630)

 

As at 31 December 2013, the total interest sensitivity gap for interest bearing items was £69,519,409.

 

As at 31 December 2013, interest rates reported by the Bank of England were 0.5% which would equate to income of £347,597 per annum if interest bearing assets remained constant. If interest rates were to fluctuate by 0.25%, this would have a positive or negative effect of £173,799 on the Group's annual income.

 

Capital risk management

 

The capital structure of the Company consists of proceeds raised from the issue of Ordinary Shares. As at 31 December 2013, the Group is not subject to any external capital requirement.

 

The Board of Directors believe that at the date of the Consolidated Statement of Financial Position there were no material risks associated with the management of the Company's capital.

 

 

-Ends-

 

Enquiries: 

 

FTI Consulting +44 (0)20 7831 3113

Jonathon Brill

 

Numis Securities Limited (Broker) +44 (0)20 7260 1275

David Benda

 

Sherborne Investors (Guernsey) B Limited +44 (0)14 8171 3843

Talmai Morgan (Chairman)

John Ellman-Brown (Administrator)

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR PGUMGWUPCGGB
Date   Source Headline
15th Oct 202111:58 amRNSResult of Extraordinary General Meeting
15th Oct 20217:30 amRNSSuspension - Sherborne Investors (Guersey) B Ltd
1st Oct 20217:00 amRNSEGM Notice/Intention to Cancel Admission of Shares
20th Aug 20217:00 amRNSHalf-year Report
17th Aug 20214:41 pmRNSSecond Price Monitoring Extn
17th Aug 20214:35 pmRNSPrice Monitoring Extension
16th Aug 20219:05 amRNSSecond Price Monitoring Extn
16th Aug 20219:00 amRNSPrice Monitoring Extension
1st Jul 202111:24 amRNSHolding(s) in Company
21st Jun 20214:41 pmRNSSecond Price Monitoring Extn
21st Jun 20214:35 pmRNSPrice Monitoring Extension
21st Jun 20217:00 amRNSDividend Declaration
18th Jun 20213:48 pmRNSStatement re Investment in Electra
18th Jun 20213:38 pmRNSHolding(s) in Company
26th May 20215:30 pmRNSResult of AGM
5th May 20217:00 amRNSNotice of AGM
16th Apr 20219:05 amRNSSecond Price Monitoring Extn
16th Apr 20219:00 amRNSPrice Monitoring Extension
16th Apr 20217:00 amRNSAnnual Financial Report
16th Apr 20217:00 amRNSFinal Results
18th Dec 20204:00 pmRNSHolding(s) in Company
18th Nov 20207:00 amRNSHolding(s) in Company
13th Nov 202011:05 amRNSSecond Price Monitoring Extn
13th Nov 202011:00 amRNSPrice Monitoring Extension
20th Aug 20207:00 amRNSHalf-year Report
5th Jun 20204:40 pmRNSSecond Price Monitoring Extn
5th Jun 20204:36 pmRNSPrice Monitoring Extension
3rd Jun 20207:00 amRNSHolding(s) in Company
27th May 20205:23 pmRNSResult of AGM
27th Apr 20205:30 pmRNSNotice of AGM
20th Apr 20207:00 amRNSFinal Results
20th Apr 20207:00 amRNSAnnual Financial Report
17th Dec 20197:00 amRNSDividend Declaration
16th Dec 20197:00 amRNSHolding(s) in Company
13th Dec 20197:00 amRNSHolding(s) in Company
20th Aug 20197:00 amRNSHalf-year Report
4th Jun 20195:48 pmRNSResult of AGM
30th Apr 20194:07 pmRNSNotice of AGM
30th Apr 20197:00 amRNSAnnual Financial Report
30th Apr 20197:00 amRNSFinal Results
6th Mar 20197:00 amRNSDividend Declaration
14th Feb 20195:40 pmRNSHolding(s) in Company
5th Nov 20187:00 amRNSDividend Declaration
8th Aug 20187:00 amRNSHalf-year Report
4th Jun 20187:00 amRNSDividend Declaration
30th May 20187:00 amRNSHolding(s) in Company
22nd May 20184:18 pmRNSResult of AGM
18th Apr 20187:02 amRNSAnnual Financial Report
18th Apr 20187:00 amRNSNotice of AGM
18th Apr 20187:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.